We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

9 hedge funds and large institutions have $2.06M invested in PAVmed Inc. Series Z Warrant in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more capital invested

Capital invested by funds: $533K → $2.06M (+$1.53M)

50% more funds holding

Funds holding: 6 → 9 (+3)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
+$784K
2
WAM
Wolverine Asset Management
Illinois
+$314K
3
WAM
Warberg Asset Management
Illinois
+$26.7K
4
UBS Group
UBS Group
Switzerland
+$3.6K

Top Sellers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
-$578K
2
TWA
TCI Wealth Advisors
Arizona
-$201

PAVMZ Hedge Fund Activity: Q1 2021 in Review

9 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2021, worth a combined $2.06M — up 286% from $533K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PAVMZ positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Raymond James & Associates, opening a new position worth an estimated $784K. The largest seller was Levin Capital Strategies, cutting an estimated $578K.

  • 9 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2021, up from 6 in Q4 2020.
  • Funds reported $2.06M of PAVmed Inc. Series Z Warrant stock for Q1 2021, up 286% quarter-over-quarter.
  • 3 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2021 and 0 closed out, a net change of +3 holders.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q1 2021 was Raymond James & Associates, an estimated $784K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q1 2021 was Levin Capital Strategies, an estimated $578K sold.

Based on aggregated 13F filings for Q1 2021.